Internationalisation of pharmaceutical R&D: how globalised are Europe's largest multinational companies?

References

• Abramovsky , L. , Harrison , R. and Simpson , H. 2006 . “ University research and the location of business R&D ” . London Institute for Fiscal Studies Report WP07/02
   Google Scholar
• Archibugi , D. and Michie , J. 1995 . The globalization of technology – a new taxonomy . Cambridge Journal of Economics , 19 : 121 – 40 .
   Web of Science ®Google Scholar
• Arundel , A. and Geuna , A. 2004 . Proximity and the use of public science by innovative European companies . Economics of Innovation and New Technology , 13 : 559 – 80 .
   Google Scholar
• Beise , M. 2004 . Lead markets: country-specific drivers of the global diffusion of innovations . Research Policy , 33 : 997 – 1018 .
   Web of Science ®Google Scholar
• Bower , D. 1993 . New technology supply networks in the global pharmaceutical industry . International Business Review , 2 : 83 – 95 .
   Google Scholar
• Calero , C. , Van Leeuwen , T. N. and Tijssen , R. J.W. 2007 . Research cooperation within the bio-pharmaceutical industry: network analyses of co-publications within and between companies . Scientometrics , 71 : 87 – 99 .
   Web of Science ®Google Scholar
• Cantell , J. 1991 . “ The international agglomeration of R&D ” . In Global research strategy and international competitiveness , Edited by: Casson , M. 104 – 32 . Oxford : Blackwell .
   Google Scholar
• Cardinal , L. and Hatfield , D. 2000 . Internal knowledge generation: the research laboratory and innovative productivity in the pharmaceutical industry . Journal of Engineering and Technology Management , 17 : 247 – 71 .
   Web of Science ®Google Scholar
• Chan , P. 2006 . All eyes on early-stage assets . The Scrip , 100 : 35 – 7 .
   Google Scholar
• Cockburn , I. and Henderson , R. 1996 . Public–private interaction in pharmaceutical research . Proceedings of the National Academy of Sciences of the United States of America , 93 : 12725 – 30 .
   PubMed Web of Science ®Google Scholar
• Coombs , R. and Metcalfe , J. 2002 . Innovation in pharmaceutical perspectives on the co-ordination, combination and creation of capabilities . Technology Analysis & Strategic Management , 14 : 261 – 72 .
   Web of Science ®Google Scholar
• Criscuolo , P. and Narula , R. 2007 . Using multi-hub structures for international R&D: organizational inertia and the challenges of implementation . Management International Review , 46 : 639 – 60 .
   Google Scholar
• Drews , J. 1989 . Research in the pharmaceutical industry . European Management Journal , 7 : 23 – 30 .
   Google Scholar
• DTI . 2006 . “ Universities enhance competitiveness and quality of life in the UK ” . London Report by UK Department of Trade & Industry and Higher Education Funding Council for England
   Google Scholar
• EC . 2005 . EU industrial R&D investment scoreboard – Vol. II , Brussels : European Commission .
   Google Scholar
• EFPIA . 2006 . The pharmaceutical industry in figures , Brussels : European Federation of Pharmaceutical Industries and Associations .
   Google Scholar
• Gambardella , A. 1995 . Science and innovation: the US pharmaceutical industry during the 1980s , Cambridge : Cambridge University Press .
   Google Scholar
• Gassman , O. and Von Zedtwitz. , M. 1999 . New concepts and trends in international R&D . Research Policy , 28 : 231 – 50 .
   Web of Science ®Google Scholar
• Gassman , O. and Reepmeyer , G. 2005 . Organizing pharmaceutical innovation: from science-based knowledge creators to drug-oriented knowledge brokers . Creativity and Innovation Management , 14 : 233 – 45 .
   Google Scholar
• Hicks , D. 1995 . Tacit competences and corporate management of the public/private character of knowledge . Industrial and Corporate Change , 4 : 401 – 24 .
   Google Scholar
• Jones , O. 2000 . Innovation management as a post-modern phenomenon: the outsourcing of pharmaceutical R&D . British Journal of Management , 11 : 341 – 56 .
   Web of Science ®Google Scholar
• Kettler , H. 2001 . “ The role of the external network in the pharmaceutical R&D process: alliances and licensing strategies ” . In Consolidation and competition in the pharmaceutical industry , Edited by: Kettler , H. 106 – 17 . London : Office of Health Economics .
   Google Scholar
• Koenig , M. 1983 . A bibliometric analysis of pharmaceutical research . Research Policy , 12 : 15 – 36 .
   Web of Science ®Google Scholar
• Kuemmerle , W. 1999 . Foreign direct investment in industrial research in the pharmaceutical and electronics: results from a survey of multinational firms . Research Policy , 28 : 179 – 93 .
   Web of Science ®Google Scholar
• McKelvey , M. , Orsenigo , L. and Pammolli , F. 2004 . “ Pharmaceuticals analysed through the lens of a sectoral innovation system ” . In Sectoral systems of innovation , Edited by: Malerba , F. 73 – 120 . Cambridge : Cambridge University Press .
   Google Scholar
• McMillan , G. and Hamilton , R. 2000 . Using bibliometrics to measure company knowledge: an analysis of the US pharmaceutical industry . Technology Analysis and Strategic Management , 12 : 465 – 75 .
   Web of Science ®Google Scholar
• Narin , F. and Rozek , R. 1988 . Bibliometric analysis of bibliometric analysis of United States pharmaceutical industry research performance . Research Policy , 17 : 139 – 54 .
   Web of Science ®Google Scholar
• OECD . 2005 . Handbook on economic globalisation indicators , Paris : Organisation of Economic Cooperation and Development .
   Google Scholar
• Orsenigo , L. , Pammolli , F. and Riccaboni , M. 2001 . Technological change and network dynamics lessons from the pharmaceutical industry . Research Policy , 30 : 485 – 508 .
   Web of Science ®Google Scholar
• Patel , P. and Pavitt , K. 1991 . Large firms in the production of the world's technology – an important case of non-globalization . Journal of International Business Studies , 22 : 1 – 21 .
   Web of Science ®Google Scholar
• Pisano , G. , Shan , W. and Teece , D. 1988 . “ Joint ventures and collaboration in the biotechnology industry ” . In International collaborative ventures in US manufacturing , Edited by: Mowery , D. 183 – 222 . Cambridge : Ballinger .
   Google Scholar
• Powell , W. 1998 . Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries . California Management Review , 40 : 228 – 40 .
   Web of Science ®Google Scholar
• Roijakkers , N. and Hagedoorn , J. 2005 . Inter-company R&D partnering in pharmaceutical biotechnology since 1975: trends, patterns, and networks . Research Policy , 35 : 431 – 46 .
   Web of Science ®Google Scholar
• Rugman , A. and Brain , C. 2004 . Regional strategies of multinational pharmaceutical firms . Management International Review , 44 : 7 – 25 .
   Google Scholar
• PWC . 2007 . “ Pharma 2020: the vision – which path will you take? Report by PriceWaterhouseCoopers ” . http://www.pwc.com(accessed 18 June 2007)
   Google Scholar
• Tapon , F. and Thong , M. 1999 . Research collaborations by multinational research oriented pharmaceutical firms: 1988–1997 . R&D Management , 29 : 219 – 31 .
   Web of Science ®Google Scholar
• Tijssen , R. J.W. 2004 . Is the commercialisation of scientific research affecting the production of public knowledge? Global trends in the output of corporate research articles . Research Policy , 33 : 709 – 33 .
   Web of Science ®Google Scholar
• Tijssen , R. J.W. 2006 . “ International benchmarking of research performance in clinical pharmacology ” . The Hague Report to Netherlands Association of Research-based Pharmaceutical Industries (NEFARMA)
   Google Scholar
• Thursby , J. and Thursby , M. 2006 . Where is the new science in corporate R&D? . Science , 314 : 1547 – 448 .
   PubMed Web of Science ®Google Scholar
• Walsh , V. and Galimberti , I. 1993 . “ Firm strategies, globalisation and new technological paradigms: the case of biotechnology ” . In The impact of globalisation on Europe's firms and industries , Edited by: Humbert , M. 175 – 90 . London : Pinter .
   Google Scholar
• Walsh , V. and Lodorfos , G. 2002 . Technological and organisational innovation in chemicals and related products . Technology Analysis & Strategic Management , 14 : 273 – 98 .
   Web of Science ®Google Scholar
• Whittaker , E. and Bower , D. 1994 . A shift to external alliances for product development in the pharmaceutical industry . R&D Management , 24 : 249 – 60 .
   Web of Science ®Google Scholar